Seroatlas · Human Serome Atlas

SIGLEC5

Sialic acid-binding Ig-like lectin 5

Also known as: CD170, CD33L2, OB-BP2, SIGL5_HUMAN, SIGLEC-5

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
O15389
Gene
SIGLEC5
Ensembl
ENSG00000268500
Chromosome
19
Canonical length
551 aa
Protein class
CD markers, Predicted membrane proteins

OverviewNCBI Gene

This gene encodes a member of the sialic acid-binding immunoglobulin-like lectin (Siglec) family. These cell surface lectins are characterized by structural motifs in the immunoglobulin (Ig)-like domains and sialic acid recognition sites in the first Ig V set domain. The encoded protein is a member of the CD33-related subset of Siglecs and inhibits the activation of several cell types including monocytes, macrophages and neutrophils. Binding of group B Streptococcus (GBS) to the encoded protein plays a role in GBS immune evasion. [provided by RefSeq, Feb 2012]

Canonical amino-acid sequenceUniProt

551 residues, UniProt reviewed canonical sequence.

>O15389|SIGLEC5
     1  MLPLLLLPLL WGGSLQEKPV YELQVQKSVT VQEGLCVLVP CSFSYPWRSW YSSPPLYVYW
    61  FRDGEIPYYA EVVATNNPDR RVKPETQGRF RLLGDVQKKN CSLSIGDARM EDTGSYFFRV
   121  ERGRDVKYSY QQNKLNLEVT ALIEKPDIHF LEPLESGRPT RLSCSLPGSC EAGPPLTFSW
   181  TGNALSPLDP ETTRSSELTL TPRPEDHGTN LTCQMKRQGA QVTTERTVQL NVSYAPQTIT
   241  IFRNGIALEI LQNTSYLPVL EGQALRLLCD APSNPPAHLS WFQGSPALNA TPISNTGILE
   301  LRRVRSAEEG GFTCRAQHPL GFLQIFLNLS VYSLPQLLGP SCSWEAEGLH CRCSFRARPA
   361  PSLCWRLEEK PLEGNSSQGS FKVNSSSAGP WANSSLILHG GLSSDLKVSC KAWNIYGSQS
   421  GSVLLLQGRS NLGTGVVPAA LGGAGVMALL CICLCLIFFL IVKARRKQAA GRPEKMDDED
   481  PIMGTITSGS RKKPWPDSPG DQASPPGDAP PLEEQKELHY ASLSFSEMKS REPKDQEAPS
   541  TTEYSEIKTS K

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against SIGLEC5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.41
Highest tissue expression
28 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 28 nTPM
  • appendix: 12 nTPM
  • spleen: 9.6 nTPM
  • lymph node: 4.6 nTPM
  • lung: 2.7 nTPM
  • tonsil: 2.6 nTPM

Single-cell type

  • neutrophils: 424 nCPM
  • neutrophil progenitors: 133 nCPM
  • monocytes: 28 nCPM
  • kupffer cells: 26 nCPM
  • hofbauer cells: 22 nCPM
  • monocyte progenitors: 16 nCPM

Immune cell

  • neutrophil: 285 nTPM
  • non-classical monocyte: 96 nTPM
  • intermediate monocyte: 46 nTPM
  • classical monocyte: 45 nTPM
  • myeloid DC: 31 nTPM
  • basophil: 26 nTPM

Brain region

  • cerebral cortex: 9.5 nTPM
  • pons: 3.5 nTPM
  • white matter: 2.6 nTPM
  • thalamus: 1.9 nTPM
  • medulla oblongata: 1.8 nTPM
  • spinal cord: 1.6 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.98
gnomAD pLI
0
gnomAD missense Z
-0.24
DepMap mean gene effect
0.16
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of SIGLEC5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads SIGLEC5 as an antibody target. Whether an autoantibody or antibody against SIGLEC5 could matter depends on whether native SIGLEC5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

SIGLEC5 is annotated at the cell surface, where native SIGLEC5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label SIGLEC5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/SIGLEC5. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...